Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate?

Carregando...
Imagem de Miniatura
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
INFORMA HEALTHCARE
Citação
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, v.43, n.6, p.503-511, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: To assess ovarian reserve markers and anti-corpus luteum antibodies (anti-CoL) in adult patients with childhood-onset systemic lupus erythematosus (c-SLE). Method: Fifty-seven adult c-SLE female patients and 21 healthy controls were evaluated for anti-CoL. Ovarian reserve was assessed by: follicle stimulating hormone (FSH), luteinizing hormone (LH), oestradiol, anti-Mullerian hormone (AMH), and antral follicle count (AFC). Demographic data, menstrual abnormalities, disease activity, damage, and treatment were also analysed. Results: The median current age was similar in adult c-SLE patients and controls (27.7 vs. 27.7 years, p = 0.414). The medians of AMH (1.1 vs. 1.5 ng/mL, p = 0.037) and AFC (6 vs. 16, p < 0.001) were significantly reduced in SLE patients compared to controls without significant menstrual abnormalities. Anti-CoL were solely observed in c-SLE patients (16% vs. 0%, p = 0.103) and were not associated with demographic data, ovarian reserve parameters, disease activity/damage, and treatment. Further evaluation of c-SLE patients treated with cyclophosphamide revealed a higher median of FSH levels compared to c-SLE patients not treated with cyclophosphamide and controls (8.8 vs. 5.7 vs. 5.6 IU/L, p = 0.032) and lower median AMH (0.4 vs. 1.5 vs. 1.5 ng/mL, p = 0.004) and AFC (4.0 vs. 6.5 vs. 16 IU/L, p = 0.001) levels. Nineteen patients treated exclusively with methotrexate demonstrated a negative correlation between the cumulative dose and AMH levels (p = 0.027, r = -0.507). Conclusions: The present study demonstrated for the first time that a high cumulative methotrexate dose is a possible cause of subclinical ovarian dysfunction in adult c-SLE patients. Further studies are required to confirm this deleterious effect in other rheumatic diseases, particularly juvenile idiopathic arthritis and idiopathic inflammatory myopathy.
Palavras-chave
Referências
  1. Aikawa NE, 2010, CLIN EXP RHEUMATOL, V28, P571
  2. Aikawa NE, 2012, CLIN EXP RHEUMATOL, V30, P445
  3. [Anonymous], 1991, BRAZ SOC CLASS ACC B, P1
  4. Appenzeller S, 2008, RHEUMATOL INT, V28, P567, DOI 10.1007/s00296-007-0478-3
  5. Arbo E, 2007, HUM REPROD, V22, P3192, DOI 10.1093/humrep/dem258
  6. BONFA E, 1987, NEW ENGL J MED, V317, P265, DOI 10.1056/NEJM198707303170503
  7. BOUMPAS DT, 1993, ANN INTERN MED, V119, P366
  8. BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
  9. Browne H, 2009, FERTIL STERIL, V91, P1529, DOI 10.1016/j.fertnstert.2008.08.123
  10. Brunner HI, 2006, LUPUS, V15, P198, DOI 10.1191/0961203306lu2291oa
  11. Clark CA, 2014, HUM REPROD, V29, P184, DOI 10.1093/humrep/det413
  12. de Sousa DC, 2005, LUPUS, V14, P618, DOI 10.1191/0961203305lu2178oa
  13. ELKON KB, 1984, J IMMUNOL, V132, P2350
  14. Ghaleb RM, 2013, JOINT BONE SPINE, V80, P434, DOI 10.1016/j.jbspin.2012.10.016
  15. GHARAVI AE, 1987, ANN RHEUM DIS, V46, P1, DOI 10.1136/ard.46.1.1
  16. Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303
  17. Gladman DD, 2002, J RHEUMATOL, V29, P288
  18. Gol M, 2009, J OBSTET GYNAECOL RE, V35, P429, DOI 10.1111/j.1447-0756.2008.00945.x
  19. Hendriks DJ, 2005, FERTIL STERIL, V83, P291, DOI 10.1016/j.fernstert.2004.10.011
  20. Hendriks DJ, 2007, FERTIL STERIL, V87, P764, DOI 10.1016/j.fertnstert.2006.11.006
  21. Lawrenz B, 2011, LUPUS, V20, P1193, DOI 10.1177/0961203311409272
  22. Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
  23. Jayaprakasan K, 2010, FERTIL STERIL, V93, P855, DOI 10.1016/j.fertnstert.2008.10.042
  24. Kristensen SL, 2012, FERTIL STERIL, V97, P779, DOI 10.1016/j.fertnstert.2011.12.017
  25. KURATA N, 1976, ARTHRITIS RHEUM, V19, P574, DOI 10.1002/art.1780190309
  26. Lehman TJA, 2004, ANN RHEUM DIS, V63, P321, DOI 10.1136/ard.2003.008342
  27. MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291
  28. Medeiros PB, 2009, LUPUS, V18, P38, DOI 10.1177/0961203308094652
  29. Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54
  30. Micu MC, 2011, ARTHRIT CARE RES, V63, P1334, DOI 10.1002/acr.20510
  31. Mok CC, 2013, ARTHRITIS RHEUM-US, V65, P206, DOI 10.1002/art.37719
  32. Mok CC, 1998, ARTHRITIS RHEUM, V41, P831
  33. Nelson SM, 2009, HUM REPROD, V24, P867, DOI 10.1093/humrep/den480
  34. Pasoto SG, 2002, LUPUS, V11, P175, DOI 10.1191/0961203302lu163oa
  35. Pasoto SG, 1999, J RHEUMATOL, V26, P1087
  36. Practice Committee of the American Society for Reproductive Medicine, 2012, FERTIL STERIL, V98, P1407
  37. Rabelo CN, 2013, CLIN RHEUMATOL, V32, P109, DOI 10.1007/s10067-012-2083-4
  38. Silva CA, 2010, RHEUMATOL INT, V31, P1037
  39. Silva CA, 2012, ARTHRIT CARE RES, V64, P1787, DOI 10.1002/acr.21757
  40. Silva CA, 2010, ARTHRIT CARE RES, V62, P1682, DOI 10.1002/acr.20323
  41. Silva CAA, 2002, J RHEUMATOL, V29, P2000
  42. Silva CAA, 2008, J RHEUMATOL, V35, P1414
  43. Silva CAA, 2002, LUPUS, V11, P419, DOI 10.1191/0961203302lu219oa
  44. Silva CAA, 2007, LUPUS, V16, P531, DOI 10.1177/0961203307079300
  45. Silva CAA, 2007, LUPUS, V16, P593, DOI 10.1177/096120330707077538
  46. Soares PMF, 2007, ARTHRITIS RHEUM, V56, P2352, DOI 10.1002/art.22660
  47. Suehiro RM, 2008, RHEUMATOLOGY, V47, P1692, DOI 10.1093/rheumatology/ken338
  48. Vecchi AP, 2011, LUPUS, V20, P512, DOI 10.1177/0961203310384121